Evidence map›Paper›PMID 25520427›Full record

Trial reportThe Journal of infectious diseases2015

IFNγ Responses to Pre-erythrocytic and Blood-stage Malaria Antigens Exhibit Differential Associations With Past Exposure and Subsequent Protection.

Prasanna Jagannathan, Felistas Nankya, Cristina Stoyanov, Ijeoma Eccles-James, Esther Sikyomu, Kate Naluwu, Samuel Wamala, Mayimuna Nalubega, Jessica Briggs, Katherine Bowen and 5 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Interferon-PeerJ · 2017
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Prasanna JagannathanDepartment of Medicine, San Francisco General Hospital, University of California.
Felistas NankyaInfectious Diseases Research Collaboration.
Cristina StoyanovDepartment of Medicine, San Francisco General Hospital, University of California.
Ijeoma Eccles-JamesDepartment of Medicine, San Francisco General Hospital, University of California.
Esther SikyomuInfectious Diseases Research Collaboration.
Kate NaluwuInfectious Diseases Research Collaboration.
Samuel WamalaInfectious Diseases Research Collaboration.
Mayimuna NalubegaInfectious Diseases Research Collaboration.
Jessica BriggsDepartment of Medicine, San Francisco General Hospital, University of California.
Katherine BowenDepartment of Medicine, San Francisco General Hospital, University of California.
Victor BigiraInfectious Diseases Research Collaboration.
James KapisiInfectious Diseases Research Collaboration.
Moses R KamyaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Grant DorseyDepartment of Medicine, San Francisco General Hospital, University of California.
Margaret E FeeneyDepartment of Medicine, San Francisco General Hospital, University of California Department of Pediatrics, University of California, San Francisco.
Infectious Diseases Research Collaboration · UGSan Francisco General Hospital · USMakerere University · UG

Funding

The immunologic consequences of prenatal exposure to malariaP01HD059454 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2008 to 2017
$22.6M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
Mentoring Translational Researchers for Careers in Pediatric Global HealthK24AI113002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2014 to 2023
$1.9M
Immunologic Consequences of Highly Effective Antimalarial ChemopreventionK23AI100949 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANNATHAN, PRASANNA · 2012 to 2016
$657k
NCATS NIH HHS KL2TR00014NCATS NIH HHS KL2 TR000143NIAID NIH HHS K23 AI100949NIAID NIH HHS K23AI100949NIAID NIH HHS K24 AI113002NIAID NIH HHS K24AI113002NIAID NIH HHS R01 AI093615NIAID NIH HHS R01AI093615NICHD NIH HHS HD059454NICHD NIH HHS P01 HD059454
6 · The paper itself

Abstract

backgroundThe malaria-specific T-cell response is believed to be important for protective immunity. Antimalarial chemoprevention may affect this response by altering exposure to malaria antigens.

methodsWe performed interferon γ (IFNγ) ELISpot assays to assess the cellular immune response to blood-stage and pre-erythrocytic antigens longitudinally from 1 to 3 years of age in 196 children enrolled in a randomized trial of antimalarial chemoprevention in Tororo, Uganda, an area of high transmission intensity.

resultsIFNγ responses to blood-stage antigens, particularly MSP1, were frequently detected, strongly associated with recent malaria exposure, and lower in those adherent to chemoprevention compared to nonadherent children and those randomized to no chemoprevention. IFNγ responses to pre-erythrocytic antigens were infrequent and similar between children randomized to chemoprevention or no chemoprevention. Responses to blood-stage antigens were not associated with subsequent protection from malaria (aHR 0.96, P = .83), but responses to pre-erythrocytic antigens were associated with protection after adjusting for prior malaria exposure (aHR 0.52, P = .009).

conclusionsIn this high transmission setting, IFNγ responses to blood-stage antigens were common and associated with recent exposure to malaria but not protection from subsequent malaria. Responses to pre-erythrocytic antigens were uncommon, not associated with exposure but were associated with protection from subsequent malaria.

Indexed as

Antigens, ProtozoanChemopreventionChild, PreschoolEnzyme-Linked Immunospot AssayFemaleHumansInfantInterferon-gammaLongitudinal StudiesMalariaMalePlasmodiumT-LymphocytesUgandaAntigens, ProtozoanInterferon-gammaantimalarial chemopreventionfalciparumIFNγimmunitymalariaT cell

Identifiers

PMID25520427
PMCPMC4836719
OpenAlexW2126027528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.